Kevin Kaplan, MD
Orthopaedic Surgery · Jacksonville, FLNPI 1164628830
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (39.2%), speaking fees and education — rather than concentrated in one kind of arrangement. Arthrex accounts for 76.6% of it on its own, with 12 other manufacturers making up the rest.
Across 44 payments — averaging $304.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$10K
- Team 1, LLC$2K
- Zimmer Biomet$227
- Johnson & Johnson$188
- Theratechnologies Inc.$120
- Smith+Nephew$114
- plus $225 from 7 others
What the payments were for
- Consulting fees$5,25039%
- Speaking & faculty fees$5,00037%
- Food & beverage$9137%
- Education$2,22417%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 9 | $10,250 |
| Team 1, LLC | 10 | $2,262 |
| Zimmer Biomet | 1 | $227 |
| Johnson & Johnson | 9 | $188 |
| Theratechnologies Inc. | 1 | $120 |
| Smith+Nephew | 2 | $114 |
| Amgen | 6 | $79 |
| Medtronic | 1 | $58 |
| Bioventus LLC | 1 | $25 |
| Cadwell Industries, Inc | 1 | $18 |
| Pacira Pharmaceuticals Incorporated | 1 | $16 |
| Curonix LLC | 1 | $15 |
| Dynasplint Systems Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SHOULDER INSTRUMENTS LIMB POSITIONERS SHOULDER SUSPENSION SYSTEM$1,500
- SHOULDER IMPLANTS CORKSCREWS KNOTLESS$1,000
- EGRIFTA SV$120
How this compares
$13,387 in reported general payments places this provider in the 65th percentile of 1,263 orthopaedic surgery providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 107 | $1,255 |
| Diclofenac Sodium | 71 | $1,120 |
| Celecoxib | 16 | $795 |
| Cephalexin | 99 | $339 |
| Ibuprofen | 27 | $184 |
| Methylprednisolone | 18 | $98 |
| Cyclobenzaprine Hcl | 12 | $94 |
| Tramadol Hcl | 31 | $56 |
| Clindamycin Hcl | 16 | $48 |
| Meloxicam | 39 | $43 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Jacksonville
- Bryan SpringerJacksonville$6.3M
- Jorge AcevedoJacksonville$3.3M
- Rahul DeshmukhJacksonville$769K
- Andrew CooperClearwater$102M
- Richard HynesMelbourne$34.8M
- Mark FrankleTemple Terrace$31M
- Roy SandersTemple Terrace$19.6M
- George HaidukewychOrlando$10M
- Robert SantrockFernandina Beach$7.3M
- Martin RocheFt. Lauderdale$7.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.